Skip to main content
. Author manuscript; available in PMC: 2014 Nov 1.
Published in final edited form as: Arthritis Care Res (Hoboken). 2013 Nov;65(11):1835–1843. doi: 10.1002/acr.22069

Table 4.

Mean IPQ-R Dimension Scores in Vasculitis and Other Chronic Diseases

Vasculitis* Diabetes Mellitus(18) Hypertension(19) Osteoarthritis(20) Systemic Sclerosis (10)

n = 692 n = 164 n = 514 n = 241 n = 49
Identity** 10.7 (±5.1) NC NC NC NC
Timeline 4.1 (±0.8) 3.9 (±0.8) 3.6 (±0.4) 4.2 (±0.8) 4.2 (±0.6)
Cyclical 3.2 (±1.0) 2.8 (±0.7) 3.2 (±0.8) 3.6 (±0.8) 3.5 (±1.0)
Consequences 3.8 (±0.8) 2.9 (±0.6) 2.6 (±0.6) 2.8 (±0.8) 3.8 (±0.8)
Emotional repr. 3.1 (±1.0) 2.0 (±0.6) 2.6 (±0.7) 2.4 (±0.8) 3.1 (±1.0)
Personal control 3.3 (±0.8) 3.9 (±0.6) 3.5 (±0.7) 3.1 (±0.6) 2.9 (±0.7)
Treatment control 3.3 (±0.7) 4.6 (±0.9) 3.5 (±0.6) 2.8 (±0.6) 3.0 (±0.6)
Illness coherence 3.4 (±1.0) 3.5 (±0.9) NR 3.6 (±0.8) 3.1 (±1.0)
*

Vasculitis types include Behçet’s disease (n=48), central nervous system vasculitis (n=12), eosinophilic granulomatosis with polyangiitis (Churg-Strauss) (n=121), giant cell arteritis (n=32), granulomatosis with polyangiitis (Wegener’s) (n=332), IgA vasculitis (Henoch-Schönlein) (n=12), microscopic polyangiitis (n=42), polyarteritis nodosa (n=36), and Takayasu’s arteritis (n=57).

**

Identity was scored on scale from 0–22. All other dimensions were scored on a scale from 1–5. NC = not comparable across diseases due to disease-specific modifications to IPQ-R. NR = not reported.